# Psilocybin in Functional Neurological Disorder

> **NCT05723276** · NA · ACTIVE_NOT_RECRUITING · sponsor: **King's College London** · enrollment: 24 (estimated)

## Conditions studied

- Functional Neurological Disorder

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT05723276
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-14
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05723276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05723276, "Psilocybin in Functional Neurological Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05723276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*